Your Prostrate.com logo
Google
Web yourprostate.com.au

Prostate News Archive

20-Jun-2009

  • A Better Blood Test For Prostate Cancer (Medical News Today)

    New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2 (EPCA-2), may change the way men are screened for prostate cancer - a disease that kills tens of thousands of men every year. Current standards of screening and testing for prostate cancer focus on the blood protein prostate-specific antigen (PSA) along with a digital rectal examination. [click ...


  • The Risk Of Renal Impairment In Hormone-Refractory Prostate Cancer Patients With Bone Metastases Treated With ... (Medical News Today)

    UroToday.com- Nearly one-quarter of prostate cancer (CaP) patients treated with zoledronic acid (ZA) suffer renal impairment according to a report by Dr. Oh and colleagues in the online version of Cancer.ZA is an intravenous bisphosphonate given to decrease skeletal related events in CaP patients with bone metastases. [click link for full article]


  • IMA meet on prostate enlargement (Indian Express via Yahoo! India News)

    A clinical meeting was organised on Sunday by the Indian Medical Association on Benign Prostatic Hyperplasia clinical manifestations and management . The meeting was presided over by Dr Diwakar Dalela, the HOD, Urology Department, King George s Medical University (KGMU). Around 20 to 30 doctors from all over the city attended the meting. They later approached Dr Dalela for their queries regarding ...


  • Cesium-131 From IsoRay Medical (TM), Inc. Established as a Front Line Treatment for Early Stage Prostate Cancer ... (Business Wire via Yahoo! Finance)

    CHICAGO----Investigators of a recent multi-institutional trial, led by principal investigator Bradley Prestidge, conclude that Cesium-131, a medical isotope used in low dose brachytherapy treatment for prostate cancer, "... has come into widespread use; and the clinical results of this trial are mature enough to be of immediate, important, practical use to practitioners."


  • Back to Prostate News Archive